As I said to my broker at credit swuisse, this new analyst came out with coverage on large pharma and I think except for Gilead gave all the companies a neutral.
I think it is moronic for a new analyst to come out with neutral ratings basically telling clients not to buy or sell. If his picks aren't buys he should look for new stocks.
Market Data 
Markets 
AI
